Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site


Click on country-registry for comparison

Flag Country Registry Registration periodNo. of cases included Complete FUIncomplete FU: loss to FU% with Complete FU at 5 yearsMedian FU (in months)
Alive/deadAt end of FUNo.%% lost to FU: years from diagnosis
No.%<11-33-5>5
China - Shangai1992-19952242223899.840.20.10.10.00.099.93.0
India - Chennai1990-199932831495.7144.33.10.30.30.696.34.3
India - Karunagappally1991-19974141100.000.00.00.00.00.0100.04.0
India - Mumbai1992-199491780387.611412.45.30.24.72.289.71.6
Thailand - Chiang Mai1993-19971069084.91615.19.53.80.90.985.83.6
Thailand - Lampang1990-2000158158100.000.00.00.00.00.0100.03.4
Thailand - Songkhla1990-1999846577.41922.615.53.63.60.077.46.3



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period